Meitheal Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for MEITHEAL, and what generic and branded alternatives to MEITHEAL drugs are available?
MEITHEAL has forty-nine approved drugs.
Drugs and US Patents for Meitheal
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Meitheal | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 214504-001 | Sep 6, 2022 | AP | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Meitheal | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 214505-002 | Sep 8, 2022 | AP | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Meitheal | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 210334-001 | Apr 27, 2018 | AP2 | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Meitheal | LEVOLEUCOVORIN CALCIUM | levoleucovorin calcium | SOLUTION;INTRAVENOUS | 211002-002 | Aug 16, 2019 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for MEITHEAL drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 250 mcg/0.5 mL, 1 mL PFS | ➤ Subscribe | 2012-03-30 |
Similar Applicant Names
Here is a list of applicants with similar names.